RACHEL PULVER: Open Payments
NPI 1730364563 · WEST LINN, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 20 payments from 9 companies in 2025. Trend: 2023 $314 · 2024 $377 · 2025 $648
Food & beverage: $548Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $189 |
| ABBVIE INC. | 7 | $161 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $125 |
| Lilly USA, LLC | 2 | $51 |
| UCB, Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
Products named: TREMFYA, SKYRIZI, Cabtreo, EBGLYSS, Bimzelx, BLU-U, NEMLUVIO, Rhapsido.
Industry payments across OR — which companies pay providers there.
